首页> 外国专利> COMPOSITION IN THE FORM OF POWDER CONTAINING AN EXTRACT OF CANNABIS SATIVA FOR THE TREATMENT OF INFLAMMATIONS OR INFECTIONS OR ALLERGIES OF THE RESPIRATORY SYSTEM AND /OR HYPERSECRETION OF THE MUCUS, AND DEVICE FOR ITS DOSAGE

COMPOSITION IN THE FORM OF POWDER CONTAINING AN EXTRACT OF CANNABIS SATIVA FOR THE TREATMENT OF INFLAMMATIONS OR INFECTIONS OR ALLERGIES OF THE RESPIRATORY SYSTEM AND /OR HYPERSECRETION OF THE MUCUS, AND DEVICE FOR ITS DOSAGE

机译：粉末形式的组合物含有大麻苜蓿的提取物，用于治疗呼吸系统的炎症或感染或过敏的粘液和/或粘液的过度分泌，以及其剂量的装置

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a composition in the form of powder for oral inhalation, preferably for oral aspiration, comprising an active agent, preferably said extract of a plant of the genus Cannabis, preferably of Cannabis sativa L. Furthermore, the present invention relates to said composition for use in a method for the treatment of mucus hypersecretion and/or inflammations or infections or allergies of the respiratory system, preferably diseases, symptoms or disorders associated with mucus hypersecretion, in a subject in need. Lastly, the present invention regards a device for administration to said subject in need through the inhalation route for oral aspiration.

机译：本发明涉及用于口服吸入的粉末形式的组合物，优选用于口服吸入，所述口服吸入，所述口服吸入，所述口腔吸入，所述口服吸入剂，优选所述植物的所述植物的植物的植物大麻植物，优选为大麻 Sativa L.此外，本发明涉及用于治疗粘液体系和/或呼吸系统的炎症或感染或过敏的方法的所述组合物，优选疾病，症状或疾病与粘液过度折叠相关的疾病，在需要的主题中。最后，本发明涉及通过吸入途径的用于对所需的所述受试者进行给药的装置。 展开▼

著录项

公开/公告号WO2021156839A1

专利类型

公开/公告日2021-08-12

原文格式PDF

申请/专利权人 SOFAR S.P.A.;
展开▼

申请/专利号WO2021IB51000

发明设计人 BIFFI ANDREA;FIORE WALTER;
展开▼

申请日2021-02-08

分类号A61K9;A61M15;A61K9/14;

国家 IB

入库时间 2022-08-24 20:36:20

相似文献

专利

外文文献

中文文献

1. 用于治疗粘液高分泌的含有粘液溶解剂的组合物及其给药装置 [P] . 中国专利： CN112533589A . 2021-03-19

2. 从东北婆婆纳中分离的含有大量活性成分的纯化提取物、其制备以及包含该提取物作为活性成分用于预防或治疗炎症、过敏和哮喘的组合物 [P] . 中国专利： CN104822386B . 2016.08.31

3. composition, inhaler, single dosage form, methods for making particles, to improve exacerbations induced by respiratory infection of a respiratory disorder, to prevent exacerbations induced by respiratory infection of a respiratory disorder, to reduce the incidence of infection-induced exacerbations r respiratory of a respiratory disorder, to reduce the severity of respiratory infection-induced exacerbations of a respiratory disorder, to prevent viral respiratory infection and to manufacture a controlled ribavirin dry powder inhalation particle in crystalline polymorph form, fabricated particles, treatment method, plurality of particles, and, dose container. [P] . BR112018009899A8 . 2019-02-26

机译：组合物，吸入剂，单一剂型，制备方法，改善由呼吸道疾病的呼吸道感染引起的急性发作，防止由呼吸道疾病的呼吸道感染引起的急性发作，减少由感染引起的急性发作的发生率呼吸道疾病，以减少呼吸道感染引起的呼吸道疾病加重的程度，预防病毒性呼吸道感染，并制造可控的利巴韦林干粉吸入颗粒状结晶多晶型物，制成的颗粒，治疗方法，多种颗粒，以及，剂量容器。

4. composition, inhaler, single dosage form, particle manufacturing methods, to improve respiratory infection-induced exacerbations of a respiratory disorder, to prevent respiratory infection-induced exacerbations of a respiratory disorder, to reduce the incidence of respiratory infection-induced exacerbations of a respiratory disorder, to reduce the severity of respiratory infection-induced exacerbations of a respiratory disorder, to prevent a viral respiratory infection, and to manufacture a controlled ribavirin dry powder inhalation particle in crystalline polymorph form, manufactured particles, method of treatment , plurality of particles, and dose container. [P] . BR112018009899A2 . 2018-11-06

机译：组成，吸入器，单一剂型，颗粒制造方法，以改善由呼吸道感染引起的呼吸道疾病加重，预防由呼吸道感染引起的呼吸道疾病加重，减少由呼吸道感染引起的呼吸道疾病加重的发生率，以减少由呼吸道感染引起的呼吸道疾病加重的严重性，防止病毒性呼吸道感染，并制备结晶多晶型物形式的受控的利巴韦林干粉吸入颗粒，制造的颗粒，治疗方法，多个颗粒和剂量容器。

5. sialidase catalytic domain protein, nucleic acid molecule, fusion protein, expression vector, pharmaceutical formulation, method of treatment or prevention of viral influenza virus, parainfluenza, or respiratory syncytial method of treatment or prevention of a bacterial pathogen, method of treating or preventing allergy or inflammation, method of enhancing gene application by a recombinant viral vector, method of treating or preventing influenza infection [P] . BRPI0515646A . 2008-07-15

机译：唾液酸酶催化域蛋白，核酸分子，融合蛋白，表达载体，药物制剂，病毒性流感病毒的治疗或预防方法，副流感或治疗或预防细菌病原体的呼吸道合胞方法，治疗或预防变态反应或炎症，通过重组病毒载体增强基因应用的方法，治疗或预防流感感染的方法

1. Qingfei oral liquid downregulates TRPV1 expression to reduce airway inflammation and mucus hypersecretion injury caused by respiratory syncytial virus infection and asthma in mice [J] . Xiao-Ping Jing, Wu-Ning Yan, Wei-Wei Cheng, 传统医学研究（英文版） . 2020,第004期

2. Qingkailing injection for the treatment of acute upper respiratory infection in children: a systematic review and meta-analysis [J] . Jiarui Wu, Dan Zhang, Yutong Wang, 中医科学杂志（英文） . 2017,第003期

3. Qingkailing injection for the treatment of acute upper respiratory infection in children: a systematic review and meta-analysis [J] . Jiarui Wu, Dan Zhang, Yutong Wang, 中医科学杂志(英文) . 2017,第003期

4. The efficacy of a novel formulation of tilmicosin, delivered in the drinking water for the treatment of respiratory infections in pigs [C] . L. Reeve-Johnson, T. Fears, A. Zimmerman Congress of the International Pig Veterinary Society . 1999

5. Disinfection Byproduct (DBP) Formation Potential: Algal Wastewater Treatment (A-WWT) System vs. Secondary System [D] . Sparks, Kayla. 2019

6. Hemp (Cannabis sativa L.) Seed PhenylpropionamidesComposition and Effects on Memory Dysfunction and Biomarkers of NeuroinflammationInduced by Lipopolysaccharide in Mice [O] . Yuefang Zhou, Shanshan Wang, Jianbo Ji, 2018

7. Effect of steam treatment on the chemical composition of hemp (Cannabis sativa L.) and identification of the extracted carbohydrates and other compounds [O] . Taneli Väisänen, Petri Kilpeläinen, Veikko Kitunen, 2019

1. Qingfei oral liquid downregulates TRPV1 expression to reduce airway inflammation and mucus hypersecretion injury caused by respiratory syncytial virus infection and asthma in mice [J] . Xiao-Ping Jing ,Wu-Ning Yan ,Wei-Wei Cheng . 传统医学研究（TMR） . 2020,第004期